BMC Cancer

1. ZHOU P, Zhou Y, Yang L, Liu C, et al
   Identification of the IFN-gamma/IL-4 ratio as a prognostic biomarker and development of an immune-related prognostic model in diffuse large B-cell lymphoma.
   BMC Cancer. 2025;25:1386.
   

   >> Share

   
   

   
   Int J Cancer

2. ZHAO J, Zhang Y, Li K, Xu L, et al
   Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
   Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
   

   >> Share

   
   

   
   Leuk Lymphoma

3. MEEUWES FO, Serroukh YIM, van der Poel MWM, Plattel WJ, et al
   Relapsed and refractory peripheral T-cell lymphoma; treatment, challenges and future perspectives.
   Leuk Lymphoma. 2025 Aug 28:1-16. doi: 10.1080/10428194.2025.2545927.
   

   >> Share

   
   
4. ELGHAWY O, Swami N, Hing ZA, Barta SK, et al
   Advances in T-cell lymphomas and risk factors for CNS involvement.
   Leuk Lymphoma. 2025;66:1583-1602.
   

   >> Share

   
   

   
   Leukemia

5. NADEU F, Shuai S, Clot G, Hilton LK, et al
   Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms.
   Leukemia. 2025;39:2076-2086.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share